Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ex Vivo Lymphoseek vs Vital Blue Dye in Colon Cancer
NCT01902953Phase 2Completed
- Sponsor
- Maimonides Medical Center
- Start
- Mar 2013
- Primary completion
- Jun 2016
- Modality
- Radiopharmaceutical, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of technetium tc 99m tilmanocept in colon cancer, rectal cancer, sponsored by Maimonides Medical Center. Started Mar 2013; status: completed.
02
Drugs
technetium tc 99m tilmanocept
03
Conditions
colon cancerrectal cancer
Beyond the preview
Go deeper on NCT01902953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01902953.